Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: A meta-analysis

Citation
L. Han et al., Tracking cognitive decline in Alzheimer's disease using the mini-mental state examination: A meta-analysis, INT PSYCHOG, 12(2), 2000, pp. 231-247
Citations number
54
Categorie Soggetti
Public Health & Health Care Science","Clinical Psycology & Psychiatry
Journal title
INTERNATIONAL PSYCHOGERIATRICS
ISSN journal
10416102 → ACNP
Volume
12
Issue
2
Year of publication
2000
Pages
231 - 247
Database
ISI
SICI code
1041-6102(200006)12:2<231:TCDIAD>2.0.ZU;2-1
Abstract
To estimate the annual rate of change scores (ARC) on the Mini-Mental State Examination (MMSE) in Alzheimer's disease (AD) and to identify study or po pulation characteristics that may affect the ARC estimation. Methods: MEDLI NE was searched for articles published from January 1981 to November 1997 u sing the following keywords: AD and longitudinal study or prognosis or cogn itive decline. The bibliographies of review articles and relevant papers we re searched for additional references. All retrieved articles were screened to meet the following inclusion criteria: (a) original study; (b) addresse d cognitive decline or prognosis or course of AD; (c) published in English; (d) study population included AD patients with ascertainable sample size; (e) used either clinical or pathological diagnostic criteria; (f) longitudi nal study design; and (g) used the MMSE as one of the outcome measures. Dat a were systematically abstracted from the included studies, and a random ef fects regression model was employed to synthesize relevant data across stud ies and to evaluate the effects of study methodology on ARC estimation and its effect size. Results: Of the 439 studies screened, 43 met all the inclu sion criteria. After 6 studies with inadequate or overlapping data were exc luded, 37 studies involving 3,492 AD patients followed over an average of 2 years were included in the meta-analysis. The pooled estimate of ARC was 3 .3 (95% confidence interval [CI]: 2.9-3.7). The observed variability in ARC across studies could not be explained with the covariates we studied, wher eas part of the variability in the effect size of ARC could be explained by the minimum MMSE score at en try and number of assessments. Conclusions: A pooled average estimate of ARC in AD patients was 3.3 points (95% CI: 2.9- 3.7) on the MMSE. Significant heterogeneity of ARC estimates existed across the studies and cannot be explained by the study or population characteris tics investigated. Effect size of ARC was related to the initial. MMSE scor e of the study population and the number of assessments.